GlassScriptPhysician profile
Jason William Berman
NPI 1104367358
$15,976.91
in general payments reported to CMS, 2019-2025
54 companies · $2,523 in 2025
The $2,523 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $672 · 2021: $3,761 · 2022: $2,903 · 2023: $2,958 · 2024: $2,816 · 2025: $2,523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,231 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,231.45 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,503.40 | 2020-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $2,334.61 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $1,668.19 | 2020-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $1,185.79 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Esperion Therapeutics, INC. | $594.94 | 2020-2023 | Nexletol |
| Pfizer INC. | $536.87 | 2021-2025 | |
| Amgen INC. | $509.40 | 2021-2025 | Repatha, Otezla, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $490.57 | 2022-2025 | |
| Glaxosmithkline, LLC. | $490.56 | 2020-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $489.52 | 2020-2025 | |
| Eisai INC. | $474.49 | 2020-2022 | |
| Ardelyx, INC. | $432.70 | 2024-2025 | Ibsrela |
| Astellas Pharma US INC | $424.73 | 2021-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $372.23 | 2020-2025 | Jardiance |
| Amarin Pharma, INC. | $262.71 | 2019-2022 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $257.32 | 2021-2024 | Trintellix |
| Daiichi Sankyo INC. | $192.93 | 2024-2025 | Injectafer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $191.65 | 2021-2024 | Xifaxan |
| Axsome Therapeutics, INC. | $189.64 | 2023-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $159.40 | 2023-2025 | Rexulti |
| Idorsia Pharmaceuticals US INC | $147.44 | 2022-2023 | Quviviq |
| Sumitomo Pharma America, INC. | $138.25 | 2024-2025 | Gemtesa |
| E.R. Squibb & Sons, L.L.C. | $134.19 | 2019-2024 | Eliquis |
| Medtronic, INC. | $120.42 | 2021-2024 | Venaseal |
| Biohaven Pharmaceuticals, INC. | $113.09 | 2021 | |
| Paratek Pharmaceuticals, INC. | $110.28 | 2022-2024 | Nuzyra |
| Myovant Sciences INC. | $106.48 | 2021 | |
| Abbott Laboratories | $106.39 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Xeris Pharmaceuticals, INC. | $102.58 | 2023 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $94.73 | 2021-2022 | |
| Allergan, INC. | $88.86 | 2019-2020 | |
| Exact Sciences Corporation | $87.98 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $85.31 | 2024 | Voquezna |
| Mylan Specialty L.P. | $85.19 | 2022-2024 | Yupelri |
| Horizon Therapeutics Plc | $83.16 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $76.02 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $74.72 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $66.03 | 2022 | |
| Inspire Medical Systems, INC. | $52.99 | 2024 | Inspire |
| Jazz Pharmaceuticals INC. | $45.69 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $41.72 | 2022-2024 | Spravato |
| Mannkind Corporation | $40.47 | 2024 | |
| Collegium Pharmaceutical, INC. | $29.41 | 2023 | Belbuca |
| Viatris Specialty LLC | $21.36 | 2025 | Yupelri |
| Halozyme INC | $19.96 | 2023 | |
| Dexcom, INC. | $18.06 | 2022 | |
| Corium, LLC | $17.98 | 2022 | |
| Vanda Pharmaceuticals INC. | $17.52 | 2025 | Fanapt |
| Seqirus USA INC | $16.75 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Irhythm Technologies, INC. | $15.58 | 2023 | Zio Xt Patch |
| Nestle Healthcare Nutrition INC. | $14.98 | 2021 | |
| Ibsa Pharma INC. | $14.33 | 2025 | Flector, Tirosint, Licart |
| Baxter Healthcare | $14.28 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.